In MDS and myeloid malignancies with EVI1 translocations, this transcription factor can cause PTEN repression and activation of PI3K/mTOR pathways [46], thereby leading to increased cell proliferation and reduced differentiation. Here, MTOR is linked to myelodysplastic syndrome.